Sandaire, an international family investment office with a base in Singapore and Delancey, a UK focused real estate advisory company, today launch Mount Kendal in Asia. Mount Kendal is a new collaboration between Delancey and Sandaire and will be focused on delivering bespoke UK real estate investment advice to Asian investors and international family offices.
Together, the two firms bring over 45 years of experience to Mount Kendal, which was established to deliver acquisition strategies and innovative asset management initiatives. Ultimately Mount Kendal seeks to create and protect value across a myriad of multi-sector, single asset or asset portfolio investments; from office, retail, residential and logistics; to healthcare, education, equity reversions and more.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8088051-sandaire-delancey-launch-mount-kendal/
Gatesman, one of the fastest-growing, mid-size, privately owned agencies in the U.S., is increasing in size and revenue by nearly 50 percent with the acquisition of Noble Communications, an award-winning, 49-year-old marketing communications firm in the Midwest.
With the acquisition, Pittsburgh-based Gatesman grows to more than 125 employees and expands to two additional offices in Chicago and Springfield, Mo. The acquisition increases the agency’s depth of expertise in new and existing areas with combined talent from both organizations, and adds new and complementary capabilities to even better serve regional, national and international clients.
To view the multimedia release go to:
https://www.multivu.com/players/English/8131351-gatesman-acquires-nobel-communications/
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of the Fluzone® (Influenza Vaccine) portfolio for the 2017-2018 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA). Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70 million total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns.
“As we enter the Swiftwater site’s 120th year, it reminds us of our innovation and growth as we came to understand the science of influenza and its impact on human health,” said David P. Greenberg, M.D., Associate Vice President and Regional Medical Head North America, Sanofi Pasteur. “Influenza can be especially severe for the most vulnerable populations, including the elderly, young children and those with compromised immune systems; however, it can also have a serious health impact on otherwise healthy individuals. Sanofi Pasteur is and always has been deeply committed to improving public health by continuously striving to develop new vaccines and on improving existing ones.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8081151-sanofi-pasteur-influenza-vaccine-first-shipment-2017/
